Sabinsa Tag


Research support efficacy of Tetrahydrocurcuminoids as an oral care ingredient

[caption id="attachment_4757" align="alignleft" width="300"] Source:[/caption] New research has recently been published that builds upon evidence from a previous trial investigating the potential of Sabinsa’s "Curcumin C3 Reduct" ingredient in oral care applications. Tetrahydrocurcuminoids (THCs) are among the major active metabolites formed on oral curcuminoids ingestion. The myriad useful pharmacological properties...

Read MoreRead More